Consolidated Statement Of Income

KYORIN Pharmaceutical Co., Ltd. - Filing #7373032

Concept 2023-04-01 to
2023-09-30
2022-04-01 to
2022-09-30
Consolidated statement of income
Statement of income
Net sales
54,937,000,000 JPY
49,093,000,000 JPY
Cost of sales
31,292,000,000 JPY
27,481,000,000 JPY
Operating expenses
Selling, general and administrative expenses
22,500,000,000 JPY
20,833,000,000 JPY
Operating expenses
Ordinary expenses
Other operating expenses
Share of loss of entities accounted for using equity method
16,000,000 JPY
9,000,000 JPY
Net sales
Gross profit (loss)
23,645,000,000 JPY
21,611,000,000 JPY
Operating profit (loss)
1,144,000,000 JPY
777,000,000 JPY
Ordinary profit (loss)
1,387,000,000 JPY
1,171,000,000 JPY
Operating expenses
Research and development expenses
3,842,000,000 JPY
4,498,000,000 JPY
Non-operating income
Dividend income
251,000,000 JPY
236,000,000 JPY
Interest income
17,000,000 JPY
2,000,000 JPY
Other
27,000,000 JPY
106,000,000 JPY
Non-operating income
313,000,000 JPY
447,000,000 JPY
Cost of sales
Selling, general and administrative expenses
Extraordinary income
969,000,000 JPY
1,319,000,000 JPY
Non-operating expenses
Interest expenses
33,000,000 JPY
34,000,000 JPY
Other
16,000,000 JPY
8,000,000 JPY
Non-operating expenses
70,000,000 JPY
53,000,000 JPY
Extraordinary losses
8,000,000 JPY
678,000,000 JPY
Impairment losses
JPY
101,000,000 JPY
Profit (loss) before income taxes
2,349,000,000 JPY
1,812,000,000 JPY
Gross profit
Extraordinary income
Gain on sale of non-current assets
0 JPY
0 JPY
Gain on sale of investment securities
969,000,000 JPY
45,000,000 JPY
Extraordinary losses
Income taxes
591,000,000 JPY
569,000,000 JPY
Profit (loss)
1,757,000,000 JPY
1,242,000,000 JPY
Profit (loss) attributable to owners of parent
1,757,000,000 JPY
1,242,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
237,000,000 JPY
428,000,000 JPY
Foreign currency translation adjustment
90,000,000 JPY
233,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
28,000,000 JPY
-2,000,000 JPY
Remeasurements of defined benefit plans, net of tax
195,000,000 JPY
183,000,000 JPY
Other comprehensive income
551,000,000 JPY
841,000,000 JPY
Profit attributable to
Comprehensive income
2,309,000,000 JPY
2,084,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
2,309,000,000 JPY
2,084,000,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.